Literature DB >> 18794526

A catechol-O-methyltransferase that is essential for auditory function in mice and humans.

Xin Du1, Martin Schwander, Eva Marie Y Moresco, Pia Viviani, Claudia Haller, Michael S Hildebrand, Kwang Pak, Lisa Tarantino, Amanda Roberts, Heather Richardson, George Koob, Hossein Najmabadi, Allen F Ryan, Richard J H Smith, Ulrich Müller, Bruce Beutler.   

Abstract

We have identified a previously unannotated catechol-O-methyltranferase (COMT), here designated COMT2, through positional cloning of a chemically induced mutation responsible for a neurobehavioral phenotype. Mice homozygous for a missense mutation in Comt2 show vestibular impairment, profound sensorineuronal deafness, and progressive degeneration of the organ of Corti. Consistent with this phenotype, COMT2 is highly expressed in sensory hair cells of the inner ear. COMT2 enzymatic activity is significantly reduced by the missense mutation, suggesting that a defect in catecholamine catabolism underlies the auditory and vestibular phenotypes. Based on the studies in mice, we have screened DNA from human families and identified a nonsense mutation in the human ortholog of the murine Comt2 gene that causes nonsyndromic deafness. Defects in catecholamine modification by COMT have been previously implicated in the development of schizophrenia. Our studies identify a previously undescribed COMT gene and indicate an unexpected role for catecholamines in the function of auditory and vestibular sense organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794526      PMCID: PMC2567147          DOI: 10.1073/pnas.0807219105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

2.  Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice.

Authors:  Marko Huotari; Joseph A Gogos; Maria Karayiorgou; Olli Koponen; Markus Forsberg; Atso Raasmaja; Juha Hyttinen; Pekka T Männistö
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

Review 3.  Neurotransmitters and neuromodulators of the mammalian cochlea.

Authors:  M Eybalin
Journal:  Physiol Rev       Date:  1993-04       Impact factor: 37.312

4.  A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.

Authors:  Martin Schwander; Anna Sczaniecka; Nicolas Grillet; Janice S Bailey; Matthew Avenarius; Hossein Najmabadi; Brian M Steffy; Glenn C Federe; Erica A Lagler; Raheleh Banan; Rudy Hice; Laura Grabowski-Boase; Elisabeth M Keithley; Allen F Ryan; Gary D Housley; Tim Wiltshire; Richard J H Smith; Lisa M Tarantino; Ulrich Müller
Journal:  J Neurosci       Date:  2007-02-28       Impact factor: 6.167

5.  Defective myosin VIIA gene responsible for Usher syndrome type 1B.

Authors:  D Weil; S Blanchard; J Kaplan; P Guilford; F Gibson; J Walsh; P Mburu; A Varela; J Levilliers; M D Weston
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

6.  A type VII myosin encoded by the mouse deafness gene shaker-1.

Authors:  F Gibson; J Walsh; P Mburu; A Varela; K A Brown; M Antonio; K W Beisel; K P Steel; S D Brown
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

7.  Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.

Authors:  M Karayiorgou; M A Morris; B Morrow; R J Shprintzen; R Goldberg; J Borrow; A Gos; G Nestadt; P S Wolyniec; V K Lasseter
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.

Authors:  B Giros; M Jaber; S R Jones; R M Wightman; M G Caron
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

9.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

10.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.

Authors:  J Tenhunen; M Salminen; K Lundström; T Kiviluoto; R Savolainen; I Ulmanen
Journal:  Eur J Biochem       Date:  1994-08-01
View more
  35 in total

Review 1.  Deafness in the genomics era.

Authors:  A Eliot Shearer; Michael S Hildebrand; Christina M Sloan; Richard J H Smith
Journal:  Hear Res       Date:  2011-10-08       Impact factor: 3.208

Review 2.  Mechanisms in cochlear hair cell mechano-electrical transduction for acquisition of sound frequency and intensity.

Authors:  Shuang Liu; Shufeng Wang; Linzhi Zou; Wei Xiong
Journal:  Cell Mol Life Sci       Date:  2021-04-19       Impact factor: 9.261

Review 3.  Molecular Structure of the Hair Cell Mechanoelectrical Transduction Complex.

Authors:  Christopher L Cunningham; Ulrich Müller
Journal:  Cold Spring Harb Perspect Med       Date:  2019-05-01       Impact factor: 6.915

4.  Analysis of p.Gly12Valfs*2, p.Trp24* and p.Trp77Arg mutations in GJB2 and p.Arg81Gln variant in LRTOMT among non syndromic hearing loss Egyptian patients: implications for genetic diagnosis.

Authors:  Abdullah A Gibriel; Maha H Abou-Elew; Saber Masmoudi
Journal:  Mol Biol Rep       Date:  2019-02-07       Impact factor: 2.316

5.  The c.242G>A mutation in LRTOMT gene is responsible for a high prevalence of deafness in the Moroccan population.

Authors:  Majida Charif; Safaa Bounaceur; Omar Abidi; Halima Nahili; Hassan Rouba; Mostafa Kandil; Redouane Boulouiz; Abdelhamid Barakat
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

6.  Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice.

Authors:  Anne Tammimäki; Mikko Käenmäki; Oleg Kambur; Natalia Kulesskaya; Tiina Keisala; Eeva Karvonen; J Arturo García-Horsman; Heikki Rauvala; Pekka T Männistö
Journal:  Psychopharmacology (Berl)       Date:  2010-07-09       Impact factor: 4.530

7.  Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice.

Authors:  M Käenmäki; A Tammimäki; J A Garcia-Horsman; T Myöhänen; N Schendzielorz; M Karayiorgou; J A Gogos; P T Männistö
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 8.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

Review 9.  MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness.

Authors:  Lilach M Friedman; Karen B Avraham
Journal:  Mamm Genome       Date:  2009-10-30       Impact factor: 2.957

10.  Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

Authors:  Colin J D Ross; Hagit Katzov-Eckert; Marie-Pierre Dubé; Beth Brooks; S Rod Rassekh; Amina Barhdadi; Yassamin Feroz-Zada; Henk Visscher; Andrew M K Brown; Michael J Rieder; Paul C Rogers; Michael S Phillips; Bruce C Carleton; Michael R Hayden
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.